bote-bruinsma-harvard-liver-perfusion.jpg

4-27-2015

Video protocol published online, illustrating our machine perfusion technique for liver preservation.

Video here.


08-22-2014

NIH grants Organ Solutions $200,000 phase 1 STTR grant 

This is the STTR business grant granted to Organ Solutions. This non-dilutive funding will support Organ Solutions' effort in attempting to recover liver grafts currently deemed unsuitable for clinical use in liver transplantation. Using Machine Perfusion preservation technology Organ Solutions aims to recover unsuitable livers. Successful development of this technology will have a broad application from augmenting cell isolation recovery to reducing waitlist times for transplants.

About NIH STTR: The STTR program an integral source of capital for early stage U.S. small businesses that are creating innovative technologies to improve health. These programs help small businesses break into the federal research and development (R&D) arena, create life-saving technologies, and stimulate economic growth.


07-18-2014

CTV News Network Canada features Organ Solutions' Supercooling technology in an interview with Bote Bruinsma.

Video here.


largecover.gif

07-10-2014

Pioneering research by Organ Solution founders is published in the July 2014 edition of Nature Medicine.

The publication titled 'Supercooling enables long-term transplantation survival following 4 days of liver preservation' applies the subzero preservation method called 'Supercooling' to whole livers in an experimental model, and achieves survival of transplant recipients after livers were stored for 4 days. A new record for liver transplantation. Link here.


12-08-2011

NIH grants Organ Solutions $170,000 phase 1 STTR grant 

This is an STTR business grant to advance our preservation and hepatocyte isolation technology with a focus on improving cell yield and cell quality, while maintaining low costs. 

About NIH STTR: The STTR program an integral source of capital for early stage U.S. small businesses that are creating innovative technologies to improve health. These programs help small businesses break into the federal research and development (R&D) arena, create life-saving technologies, and stimulate economic growth.


11-04-2011

Organ Solutions has been granted a $550,000 non-dilutive funding by CIMIT, an Boston-based accelerator consortium.

The seed fund provides the support for further development  of a novel hepatocyte isolation technique under development by Organ Solutions through 2014.

CIMIT is a clinically-based consortium of Boston-area hospitals and engineering schools, including Mass General Hospital, Brigham and Women’s Hospital, MIT, Charles Stark Draper Laboratory, Beth Israel Deaconess Medical Center, Boston University, Boston University Medical Campus, Childrens Hospital Boston, Newton Wellesley Hospital, Northeastern University, Partners HealthCare, and VA Boston Healthcare System, CIMIT supports translational research by multidisciplinary teams for medical device and clinical technology system applications, and through seed funding and facilitation attracts world-class clinicians, scientists and engineers working together with industry and government to accelerate the clinical impact of innovative technologies.


Media


MGH Transplant Surgeon, dr. Heidi Yeh, and Organ Solutions founders (dr. Korkut Uygun, dr. Bote Bruinsma) talk about the machine perfusion preservation of the liver.

 

Organ Solutions cofounders (dr. Korkut Uygun, dr. Bote Bruinsma) at Mass General Hospital have developed a new technique that could extend the life of organs stored outside of the body before transplantation by up to three days longer than any other preservation method.